1. A Purpose-driven Company, Unilever

    05/06/2019

    Unilever brands take an active part in social change and put sustainable development at the heart of all their activities

  2. Work is Key to Completing the Rehabilitation Cycle

    03/06/2019

    Labour reintegration is one of the driving forces that helps to overcome substance use disorders, prevent relapses, and help people achieve stability

  3. Drugs and SDGs – a Guide for NGOs

    07/04/2019

    Publication of a guide to help NGOs contribute to the Outcome Document of UNGASS and to the Sustainable Development Goals (SDGs)

  4. CND62 – Overview of NGO Activities

    02/04/2019

    About 2,400 people from 140 countries attended the 62nd Session of the Commission on Narcotic Drugs and the Ministerial Segment, with a high level of participation of civil society organizations

  5. Dianova Addresses Addiction Stigma at the CND

    01/04/2019

    On March 18th, Kenneth Arctander represented Dianova International as a speaker at a side event titled ‘Addressing stigma: continuing the discussion’

  6. Treatment Services Must Address Women’s Specific Needs

    29/03/2019

    For the eighth year in a row, Dianova actively participated in the 63rd Commission on the Status of Women in New York

  7. Drug Policies: Ministerial Declaration

    25/03/2019

    The Ministerial Declaration recognizes the role of civil society in drug policies and recommends the use of evidence-based practices

  8. YourVoice+Achieving True Gender Equality

    21/03/2019

    Gisela Hansen, clinical psychologist, speaks of the YourVoice+ initiative launched by Dianova to highlights the many obstacles that prevent women’s access to equality

  9. Promoting a Gender Responsive Approach to Drugs

    08/03/2019

    Recommendations from the Civil Society Forum on Drugs on the importance of promoting gender equality to achieve a balanced approach to the drug phenomenon 

  10. Civil society Participation in UN Drug Policy Processes

    06/03/2019

    Many civil society organizations have a vision of how drug policies should be changed and are committed to actively participating in these processes